Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease
- 30 November 2006
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 373 (1-2) , 77-81
- https://doi.org/10.1016/j.cca.2006.05.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene FamilyGenomics, 1996
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteinsCurrent Opinion in Lipidology, 1996
- A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.Journal of Clinical Investigation, 1995
- Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetesThe Lancet, 1995
- HDL, its enzymes and its potential to influence lipid peroxidationAtherosclerosis, 1995
- The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidationBiochemical Journal, 1993
- Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.Journal of Clinical Investigation, 1991
- Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitusAtherosclerosis, 1991
- High-density lipoprotein inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990